Evidence map›Paper›PMID 38389702›Full record

ArticleProceedings. IEEE International Conference on Data Mining2023

Heterogeneous Treatment Effect Estimation with Subpopulation Identification for Personalized Medicine in Opioid Use Disorder.

Seungyeon Lee, Ruoqi Liu, Wenyu Song, Ping Zhang

Open access · greenAbstract read
In one paragraph

Article in Proceedings. IEEE International Conference on Data Mining, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. SubgroupTE: Advancing Treatment Effect Estimation with Subgroup Identification.ACM transactions on intelligent systems and technology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Seungyeon LeeDepartment of Computer Science and Engineering, The Ohio State University, USA.
Ruoqi LiuDepartment of Computer Science and Engineering, The Ohio State University, USA.
Wenyu SongDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA.
Ping ZhangDepartment of Computer Science and Engineering, The Ohio State University, USA.
The Ohio State University · USBrigham and Women's Hospital · US

Funding

A Statistical Network Pharmacology Approach for Early Detection of Adverse Drug EventsR01GM141279 · NIGMS · OHIO STATE UNIVERSITY · PI ZHANG, PENGYUE, ZHANG, PING · 2021 to 2023
$937k
NIGMS NIH HHS R01 GM141279
6 · The paper itself

Abstract

Deep learning models have demonstrated promising results in estimating treatment effects (TEE). However, most of them overlook the variations in treatment outcomes among subgroups with distinct characteristics. This limitation hinders their ability to provide accurate estimations and treatment recommendations for specific subgroups. In this study, we introduce a novel neural network-based framework, named SubgroupTE, which incorporates subgroup identification and treatment effect estimation. SubgroupTE identifies diverse subgroups and simultaneously estimates treatment effects for each subgroup, improving the treatment effect estimation by considering the heterogeneity of treatment responses. Comparative experiments on synthetic data show that SubgroupTE outperforms existing models in treatment effect estimation. Furthermore, experiments on a real-world dataset related to opioid use disorder (OUD) demonstrate the potential of our approach to enhance personalized treatment recommendations for OUD patients.

Indexed as

deep learningopioid use disordersubgroup analysistreatment effect estimation

Identifiers

PMID38389702
PMCPMC10883421
OpenAlexW4391529028

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.